Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 33Multiple Myeloma 30Lymphoma, Non-Hodgkin 29Hodgkin Disease 28Graft vs Host Disease 26Leukemia, Lymphocytic, Chronic, B-Cell 25Lymphoma 24Leukemia 24Hematologic Neoplasms 20Neoplasms 18Lymphoma, Mantle-Cell 18Sarcoma 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Breast Neoplasms 17Tuberous Sclerosis 15Myeloproliferative Disorders 15Lymphoma, Large B-Cell, Diffuse 15Lymphoma, Follicular 14Burkitt Lymphoma 14Waldenstrom Macroglobulinemia 13Lymphoma, B-Cell, Marginal Zone 13Recurrence 12Neoplasm Metastasis 12Carcinoma, Non-Small-Cell Lung 12Prostatic Neoplasms 11Primary Myelofibrosis 11Melanoma 11Leukemia, Myelomonocytic, Chronic 11

Interventions

nirogacestat 6Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3X-Rays 2Toremifene 2Phantoms, Imaging 2Cryosurgery 2Blood Specimen Collection 2vactosertib 1trifluridine tipiracil drug combination 1strattice 1liposomal doxorubicin 1entinostat 1anlotinib 1Vinblastine 1Taxes 1Tamoxifen 1Sunitinib 1Sulindac 1Sorafenib 1Sirolimus 1Saline Solution 1Radiotherapy 1Radiofrequency Ablation 1Oxaliplatin 1Methotrexate 1Leucovorin 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Desmoid Tumors × Sirolimus × Clear all
NCT01265030 2023-06-26

A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis

MaineHealth

Phase 1/2 Completed
9 enrolled 5 charts
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡